Deadline Extended! Send Your Case Before Friday 13th

Clinical Case Contest for Young Interventionists

In order to give opportunities to all professionals in the region, we decided to extend the deadline for submitting cases to participate in the Young Interventional Cardiologists Contest that will be held during the Paraguay 2022 Sessions for another 10 days.

New Deadline: Friday, May 13, 2022

Send us your case study before Friday, May 13th and participate in the traditional Sessions initiative where a renowned international panel of specialists will assess and appraise the work sent by young Latin American interventional cardiologists from all corners of the continent.

Important Prize for the Winning Case!

The best case study shall receive an important prize: attendance fee waiver for the incoming SOLACI Sessions to be held, including air fare, accommodation and Sessions registration.

Jornadas SOLACI Paraguay 2022

Send your case now and make part of an unmissable event!!


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

The El Salvador 2024 Sessions are coming soon

The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Virtual Event SOLACI-Medtronic | The Visible Heart Lab

We invite you to participate in a new virtual activity organized in collaboration with Medtronic, focused on "The Visible Heart Lab" and dedicated to...

SOLACI-CACI 2024 – Presentations day 3

Discover the highlights of the third day of activities of  SOLACI-CACI 2024 Congress, held from August 7 to 9 at the Hilton Hotel in Buenos Aires, Argentina. Dr....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...